| Dr Daniel G Price, MD | |
|
22 Bramhall St, Portland, ME 04102 | |
| (207) 662-4380 | |
| (207) 662-6783 |
| Full Name | Dr Daniel G Price |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 25 Years |
| Location | 22 Bramhall St, Portland, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154416667 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 016185 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Maine Medical Center | Portland, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mainehealth | 7517860588 | 2067 |
News Archive
Reporting online in the American Journal of Pathology, researchers from the Kimmel Cancer Center at Jefferson have implicated the loss of a stromal protein called caveolin-1 as a major new prognostic factor in patients with breast cancer, predicting early disease recurrence, metastasis and breast cancer patient survival.
A cholera outbreak in the Dominican Republic appears to be spreading, and health officials are reporting hundreds of new cases, the Associated Press/Washington Post reports.
Pneumococcal conjugate vaccine have been highly effective in reducing pneumonia and other invasive infections caused by Streptococcus pneumoniae bacteria.
Santarus, Inc. and Cosmo Pharmaceuticals S.p.A. today announced positive top-line results from the Phase III clinical study conducted in the U.S. and India to evaluate the safety and efficacy of budesonide MMX® for the induction of remission of mild or moderate active ulcerative colitis. The study results show that budesonide MMX 9 mg taken once daily met the primary endpoint of superiority to placebo.
› Verified 5 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Reporting online in the American Journal of Pathology, researchers from the Kimmel Cancer Center at Jefferson have implicated the loss of a stromal protein called caveolin-1 as a major new prognostic factor in patients with breast cancer, predicting early disease recurrence, metastasis and breast cancer patient survival.
A cholera outbreak in the Dominican Republic appears to be spreading, and health officials are reporting hundreds of new cases, the Associated Press/Washington Post reports.
Pneumococcal conjugate vaccine have been highly effective in reducing pneumonia and other invasive infections caused by Streptococcus pneumoniae bacteria.
Santarus, Inc. and Cosmo Pharmaceuticals S.p.A. today announced positive top-line results from the Phase III clinical study conducted in the U.S. and India to evaluate the safety and efficacy of budesonide MMX® for the induction of remission of mild or moderate active ulcerative colitis. The study results show that budesonide MMX 9 mg taken once daily met the primary endpoint of superiority to placebo.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel G Price, MD 190 Riverside St, Suite 6b, Portland, ME 04103-1073 Ph: (207) 661-2000 | Dr Daniel G Price, MD 22 Bramhall St, Portland, ME 04102 Ph: (207) 662-4380 |
News Archive
Reporting online in the American Journal of Pathology, researchers from the Kimmel Cancer Center at Jefferson have implicated the loss of a stromal protein called caveolin-1 as a major new prognostic factor in patients with breast cancer, predicting early disease recurrence, metastasis and breast cancer patient survival.
A cholera outbreak in the Dominican Republic appears to be spreading, and health officials are reporting hundreds of new cases, the Associated Press/Washington Post reports.
Pneumococcal conjugate vaccine have been highly effective in reducing pneumonia and other invasive infections caused by Streptococcus pneumoniae bacteria.
Santarus, Inc. and Cosmo Pharmaceuticals S.p.A. today announced positive top-line results from the Phase III clinical study conducted in the U.S. and India to evaluate the safety and efficacy of budesonide MMX® for the induction of remission of mild or moderate active ulcerative colitis. The study results show that budesonide MMX 9 mg taken once daily met the primary endpoint of superiority to placebo.
› Verified 5 days ago
Dr. Robert Charles King, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2 Portland Sq Ste 201, Portland, ME 04101 Phone: 207-607-4022 Fax: 207-613-5048 | |
Dr. Barbara Jane Wood, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 121 Middle St, Suite 404, Portland, ME 04101 Phone: 207-772-8634 Fax: 207-772-1629 | |
Amy Wood, PSY D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 57 Exchange St, Suite 403, Portland, ME 04101 Phone: 207-772-7542 Fax: 207-775-4454 | |
Dr. Jeremy Ashley Spiegel, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 63 Preble St, Portland, ME 04101 Phone: 207-822-0232 | |
Robert Toscano, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 165 Lancaster St, Portland, ME 04101 Phone: 207-874-1030 Fax: 207-874-1044 | |
Dr. Robert A Haines, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 477 Congress St Ste 201, Portland, ME 04101 Phone: 207-773-7811 Fax: 207-773-0663 | |
Dr. Charles J. Mallo, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 216 Vaughan St, Portland, ME 04102 Phone: 207-662-2221 Fax: 207-810-2367 |